Viva Biotech Holdings (OTCMKTS:VBIZF – Get Free Report) shares traded up 2.9% during mid-day trading on Tuesday . The company traded as high as $0.2612 and last traded at $0.2612. 500 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 3,533 shares. The stock had previously closed at $0.2538.
Viva Biotech Price Performance
The firm’s 50-day moving average is $0.29 and its 200-day moving average is $0.26.
About Viva Biotech
Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, including protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; and antibody/biologics research and development services comprising recombinant protein expression platform, antibody discovery and affinity maturation, assay platform, antibody production and identification platform, and antigen-antibody structural resolution platform solutions.
Featured Stories
- Five stocks we like better than Viva Biotech
- What Do S&P 500 Stocks Tell Investors About the Market?
- Wall Street’s Sleeping Giant: Is Amazon About to Wake Up?
- 5 discounted opportunities for dividend growth investors
- Checkmate in the Cloud: ServiceNow’s Shopping Spree
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- The Contrarian Case for MSTR Amid MSCI Delisting Debacle
Receive News & Ratings for Viva Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viva Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
